Not All Bruton’s Tyrosine Kinase Inhibitors are Created Equal: Pharmacologic Insights into the Efficacy, Resistance, and Safety of Covalent and Non-covalent BTK Inhibitors. (2026). Actualité hématologique Au Canada, 5(s02), 2–7. https://doi.org/10.58931/cht.2026.5s0282